Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular Pressure
Public ClinicalTrials.gov record NCT01060579. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-masked, Randomized, Active-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure
Study identification
- NCT ID
- NCT01060579
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Aerie Pharmaceuticals
- Industry
- Enrollment
- 217 participants
Conditions and interventions
Conditions
Interventions
- AR-12286 0.5% ophthalmic solution Drug
- AR-12286 0.25% Ophthalmic solution Drug
- Latanoprost ophthalmic solution Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2010
- Primary completion
- Jul 31, 2010
- Completion
- Jul 31, 2010
- Last update posted
- May 7, 2014
2010
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| United Medical Research Institute | Inglewood | California | 90301 | — |
| North Bay Eye Associates | Petaluma | California | 94954 | — |
| Centre For Health Care | Poway | California | 92064 | — |
| East Florida Eye Institute | Stuart | Florida | 34994 | — |
| Marvin Greenberg, MD | Tamarac | Florida | 33321 | — |
| Coastal Research Associates, LLC | Roswell | Georgia | 30076 | — |
| Bradley Kwapiszeski, MD | Shawnee Mission | Kansas | 66204 | — |
| Taustine Eye Center | Louisville | Kentucky | 40217 | — |
| Comprehensive Eye Care | St Louis | Missouri | 63090 | — |
| Mount Sinai School Of Medicine | New York | New York | 10029 | — |
| Rochester Ophthalmology Group | Rochester | New York | 14618 | — |
| Glaucoma Consultants of the Capital Region | Slingerlands | New York | 12159 | — |
| Charlotte Eye Ear Nose and Throat | Charlotte | North Carolina | 28210 | — |
| The Eye Institute | Tulsa | Oklahoma | 74104 | — |
| Black Hills Regional Eye Institute | Rapid City | South Dakota | 57701 | — |
| Univ Eye Surgeons, Maryville Ctr. | Maryville | Tennessee | 37803 | — |
| Texan Eye | Austin | Texas | 78731 | — |
| Medical Center Ophth. Associates | San Antonio | Texas | 78731 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01060579, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2014 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01060579 live on ClinicalTrials.gov.